Additionally, mice lacking PAK1 had increased number of spleen T and B cells in contrast to wild type mice developing cancer in the small intestine, distal colon and rectum, indicating that PAK1 might contribute to the tumour eradication by immune cells [34]. This evidence concerns the gene PAK1 and cancer.